|
Dr. John Abernethy is the Medical Director for Nanotherapeutics. He is currently President of AMK Research, Inc. and holds a Clinical Assistant Professor position at the University of Florida. Dr. Abernethy has had experience with all aspects of Phase I through Phase IV clinical protocols and has been involved in over 30 trials over the last 10 years.
Dr. Abernethy graduated from University of Miami and received his M.D. from the University of Florida. His graduate training was at Shands Hospital in Gainesville, Florida where he was Chief Resident in his final year of Residency. He is Board Certified in Family Medicine. | 